Helicos SeqLL Withdraws Plans for $8M IPO The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds. True Bearing Readies RNA-Based Coronary Artery Disease Diagnostic for FDA Review, Launch Premium The company is collecting validation evidence it intends to submit to the FDA next year, which will also support launch of the test as an LDT. SeqLL Launches Early Access for Revamped Helicos Platform, Expands Service Business Premium The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications. China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use Premium The company is currently working with three hospitals in China and plans to launch the GenoCare system commercially in 2017. SeqLL Plans to Revamp Helicos Technology Premium This article was originally published Sept. 29. Sep 18, 2014 SeqLL Raises $1M to Enhance Service Offerings on Helicos Single-Molecule Platform Mar 11, 2014 Pathogen Search Underscores Need for Validation Steps When Sequencing Ancient Metagenomes Premium Nov 8, 2013 Fruit Fly Study Hints at RNA Editing Effect on Transposon-related Gene Silencing Jun 17, 2013 Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche May 17, 2013 Helicos Seeks Bankruptcy Court Approval of Licensing Deals with Illumina, Life Tech, and Fluidigm Mar 11, 2013 Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company Dec 18, 2012 As Helicos Navigates Bankruptcy Process, Details Emerge on Disputes with Creditors and Customers Premium Nov 16, 2012 Helicos BioSciences Files for Chapter 11 Bankruptcy Protection Oct 2, 2012 Paired Ends: Carol Cox, Louise Mawhinney Premium Sep 11, 2012 Paired Ends: Ivan Trifunovich, Andrew Senyei, Paul Bianchi, and More Premium Sep 7, 2012 Helicos CEO Resigns Sep 4, 2012 Helicos Considers Next Moves as Remaining Patent in Illumina Suit Is Deemed Invalid Premium Sep 4, 2012 Paired Ends: Noubar Afeyan, Peter Barrett, Daniel O'Day, Pascal Soriot, Roland Diggelman Premium Aug 30, 2012 Federal Court Rules Helicos Patent Invalid; Company Reaches Payment Agreement with Lenders Aug 14, 2012 Helicos Q2 Sales Fall on Lower Grant, Service Revenues Aug 7, 2012 Helicos Licenses Patents to Intelligent Bio-Systems for $1.6M Jul 10, 2012 Helicos Drops Suit Against Life Tech, Leaving Illumina as Sole Defendant Premium May 14, 2012 Helicos Posts Sharp Drop in Q1 Revenues May 14, 2012 Helicos Confirms Licensing Deal with PacBio as Part of IP Settlement May 8, 2012 Awaiting Settlement of Patent Suit with PacBio, Helicos Sets Sights on Life Tech and Illumina Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.